Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director

Star Pharmaceutical Limited manufactures prescription drugs. The Company produces antibiotics, and cerebrovascular and cardiovascular drugs. Star markets its products in the Peoples Republic of China.

Disclosure Of Interest/ Changes In Interest Of Director/ Chief Executive Officer: Disclosure Of Interest/ Changes In Interest Of Director

General Announcement::Mandatory Unconditional Cash Offer - Completion of Compulsory Acquisition

General Announcement: Mandatory Unconditional Cash Offer - Completion Of Compulsory Acquisition

Delisting Of Security: Mandatory

General Announcement::Mandatory Unconditional Cash Offer - Exercise of Right of Compulsory Acquisition

General Announcement: Mandatory Unconditional Cash Offer - Exercise Of Right Of Compulsory Acquisition

General Announcement::Receipt of Approval-In Principle for the Delisting of the Company

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Star Pharmaceutical (STP SP)

Disclosure Of Interest/ Changes In Interest Of Director/ Chief Executive Officer: Disclosure Of Interest/ Changes In Interest Of Director

General Announcement: Mandatory Unconditional Cash Offer - Completion Of Compulsory Acquisition

Delisting Of Security: Mandatory

General Announcement: Mandatory Unconditional Cash Offer - Exercise Of Right Of Compulsory Acquisition

General Announcement: Receipt Of Approval-In Principle For The Delisting Of The Company

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)